Drug Shows ' Striking ' Efficacy in Hereditary Bleeding Disorder Drug Shows ' Striking ' Efficacy in Hereditary Bleeding Disorder
The anti-VEGF antibody has shown efficacy in the rare, underrecognized condition of hereditary hemorrhagic telangiectasia, demonstrating significant reductions in both nose and gastric bleeding.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology News Source Type: news
More News: Bleeding | Cancer & Oncology | Gastroenterology | Hematology | Hereditary Hemorrhagic Telangiectasia | Intensive Care